Xilio Therapeutics
NASDAQ: XLO
$9.00
+0.09
(+1.01%)
Live
as on
Xilio Therapeutics Stock Performance
as on October 3, 2026 at 5:46 am IST
Day's Low
Day's High
$8.90$9.04
1.11%
Downside
0.44%
Upside
52 Week's Low
52 Week's High
$6.47$12.5828.16%
Downside
39.83%
Upside
Xilio Therapeutics share price movements today
- Previous Close
- $8.91
- Open
- $9.03
- Volume
- 98.2K
- Market Cap
- $59.6M
- Day's Low - High
- $8.90 - $9.04
- 52 Week Low - High
- $6.47 - $12.58
Xilio Therapeutics Historical Returns
- 1 Month Return
- + 0.79 %
- 3 Month Return
- -2.62 %
- 1 Year Return
- -20.45 %
- 3 Year Return
- -69.69 %
- 5 Year Return
- 0 %
Xilio Therapeutics Stock Fundamentals & Key Indicators
Check Xilio Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$59.6M
EPS (TTM)
-1.49
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.07
Industry PE ratio
-2.26
PEG Ratio
-0.03
EBITDA
-20.5M
Revenue (TTM)
64.1M
Profit Margin
99.46%
Return On Equity TTM
-50.77%
Xilio Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Xilio Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $59.6M | NA | -6.07 | 99.46% | 0.00% | |
| StrongBuy | $44.0B | 607.04% | -23.17 | 0.00% | 0.00% | |
| Neutral | $76.9B | -44.61% | -24.13 | -12.57% | 0.00% | |
| StrongBuy | $132.5B | 180.98% | 30.19 | 86.04% | 0.00% | |
| Buy | $77.3B | 28.74% | 18.11 | 84.86% | 0.49% |
Stock Returns calculator for Xilio Therapeutics Stock including INR - Dollar returns
The Xilio Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Xilio Therapeutics investment value today
Current value as on today
₹87,223
Returns
Returns from Xilio Therapeutics Stock
Dollar Impact
₹6,866 (+6.87%)
Analyst Recommendation on Xilio Therapeutics Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Xilio Therapeutics. Average target price of $20
Xilio Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Xilio Therapeutics.
What analysts predicted
55%UPSIDE
Target Price
$20
Current Price
$9
Analyzed by
7 Analysts
Target
$20.00
Xilio Therapeutics target price $20, a slight upside of 55% compared to current price of $9. According to 7 analysts rating.
Xilio Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Xilio Therapeutics Annual Profit & Loss
All numbers in Millions USD
Xilio Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Xilio Therapeutics Annual Cash Flow
All numbers in Millions USD
Xilio Therapeutics News & Key Events
Insights on Xilio Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.9% return, outperforming this stock by 152.6%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.0% return, outperforming this stock by 586.4%
NEGATIVE IMPACTPrice Dip
In the last 3 years, XLO stock has moved down by -69.7%
About Xilio Therapeutics
| Organisation | Xilio Therapeutics |
| Headquarters | 828 Winter Street, Waltham, MA, 02451, US |
| Industry | Biotechnology |
| CEO | Rene Russo |
Key Management of Xilio Therapeutics
Name | Title |
|---|---|
Mr. Kevin M. Brennan | Senior Vice President of Finance & Accounting |
Dr. Uli Bialucha Ph.D. | Chief Scientific Officer |
Mr. Nathan McBride | Chief Information Officer |
Mr. Benjamin S. Harshbarger J.D. | Chief Legal Officer |
Dr. Scott Coleman Ph.D. | Chief Development Officer |
Ms. Ruth du Moulin | Senior Vice President of Medical Affairs |
Dr. Rene Russo BCPS, Pharm.D. | President, CEO & Director |
Mr. Christopher Frankenfield | CFO & COO |
FAQs
What is Xilio Therapeutics share price today?
Xilio Therapeutics share price today is $9.00 as on . Xilio Therapeutics share today touched a day high of $9.04 and a low of $8.90.
What is the 52 week high and 52 week low for Xilio Therapeutics share?
Xilio Therapeutics share touched a 52 week high of $12.58 on and a 52 week low of $6.47 on . Xilio Therapeutics stock price today i.e. is trending at $9.00,which is 28.48% down from its 52 week high and 39.21% up from its 52 week low.
What is Xilio Therapeutics's market capitalisation today?
Xilio Therapeutics market capitalisation is $0.00T as on .
How to invest in Xilio Therapeutics Stock (XLO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Xilio Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Xilio Therapeutics Stock (XLO) from India?
Indian investors can start investing in Xilio Therapeutics (XLO) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Xilio Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Xilio Therapeutics share’s latest price of $9.00 as on October 3, 2026 at 12:16 am IST, you will get 1.1111 shares of Xilio Therapeutics. Learn more about
fractional shares .